Biotechnology Companies By Pb Ratio
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Price To Book
| Price To Book | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | PTCT | PTC Therapeutics | 0.08 | 2.26 | 0.18 | ||
| 2 | INSM | Insmed Inc | 0.03 | 2.05 | 0.07 | ||
| 3 | PMN | ProMIS Neurosciences | (0.12) | 6.10 | (0.73) | ||
| 4 | FBLG | FibroBiologics, Common Stock | (0.01) | 12.18 | (0.17) | ||
| 5 | PLUR | Pluri Inc | (0.03) | 3.77 | (0.09) | ||
| 6 | AGEN | Agenus Inc | (0.13) | 9.24 | (1.16) | ||
| 7 | GALT | Galectin Therapeutics | 0.12 | 4.03 | 0.47 | ||
| 8 | INDV | Indivior PLC Ordinary | (0.07) | 5.67 | (0.41) | ||
| 9 | ALNY | Alnylam Pharmaceuticals | 0.04 | 2.49 | 0.11 | ||
| 10 | GOVX | GeoVax Labs | 0.03 | 17.42 | 0.56 | ||
| 11 | BBIO | BridgeBio Pharma | 0.00 | 3.18 | (0.01) | ||
| 12 | CARM | Carisma Therapeutics | (0.05) | 4.59 | (0.24) | ||
| 13 | ANAB | AnaptysBio | 0.13 | 3.83 | 0.52 | ||
| 14 | OCEA | Ocean Biomedical | (0.04) | 5.02 | (0.21) | ||
| 15 | ESPR | Esperion Therapeutics | (0.02) | 4.31 | (0.07) | ||
| 16 | PROK | ProKidney Corp | (0.04) | 6.08 | (0.22) | ||
| 17 | RYTM | Rhythm Pharmaceuticals | 0.08 | 2.99 | 0.24 | ||
| 18 | TVTX | Travere Therapeutics | 0.23 | 4.15 | 0.94 | ||
| 19 | CHRS | Coherus BioSciences | (0.02) | 6.28 | (0.11) | ||
| 20 | SMMT | Summit Therapeutics PLC | 0.19 | 9.53 | 1.82 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities. Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.